OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2021
(2)
2026
(1)
2024
(1)
2023
(1)
2022
(1)
2020
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Development and characterization of a novel anti-OX40 antibody for potent immune activation.
Not available
S-EPMC11027608
|
biostudies-literature
Cite
Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment.
Not available
S-EPMC9734822
|
biostudies-literature
Cite
Identification of immune-associated genes in vascular dementia by integrated bioinformatics and inflammatory infiltrates.
Not available
S-EPMC10879030
|
biostudies-literature
Cite
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity.
Not available
S-EPMC10991320
|
biostudies-literature
Cite
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells.
Not available
S-EPMC5517644
|
biostudies-literature
Cite
Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis.
Not available
S-EPMC8783423
|
biostudies-literature
Cite
Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study.
Not available
S-EPMC8444572
|
biostudies-literature
Cite
Efficacy and safety of anti-LAG-3 IBI110 in combination with sintilimab and chemotherapy for advanced squamous non-small cell lung cancer: a randomized phase II study.
Not available
S-EPMC12847551
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets